Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ferumoxytol Iron Indices Stabilization in Hemodialysis
NCT01148745Phase 4Completed
- Sponsor
- Dialysis Clinic
- Start
- Mar 2010
- Primary completion
- Apr 2010
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ferumoxytol in iron deficiency anemia (IDA), sponsored by Dialysis Clinic. Primary endpoint: Number of Weeks Until Transferrin Saturation (TSAT) and Ferritin Stabilize at 28 days. Started Mar 2010; status: completed.
02
Drugs
ferumoxytol
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT01148745.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01148745.